Skip to main content
SpringerLink
Log in

Genetic Engineering of Protein-Based Polymers: Potential in Controlled Drug Delivery

  • Commentary
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Y. Takakura and M. Hashida. Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution. Pharm. Res. 13:820-831 (1996).

    Google Scholar 

  2. J. Kopecek and P. Rejmanova. Enzymatically degradable bonds in synthetic polymers. In S. D. Bruck (ed.), Controlled Drug Delivery, Vol. I, CRC Press, Boca Raton, 1983, pp. 81-124.

    Google Scholar 

  3. D. H. Lewis. Controlled release of bioactive agents from lactide/glycolide polymers. In M. Chasin and R. Langer (eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 1-41.

    Google Scholar 

  4. F. A. Ferrari, C. Richardson, J. Chambers, S. C. Cauey, and T. J. Pollock. Patent application, international publication number W088/03533, 1986.

  5. J. Cappello. Synthetically designed protein-polymer biomaterials. In K. Park (ed.), Controlled Drug Delivery: Challenges and Strategies, American Chemical Society, Washington D.C., 1997, pp. 439-453.

    Google Scholar 

  6. M. J. Fournier, S. H. Creel, M. T. Krejchi, T. L. Mason, and D. A. Tirrell. Genetic synthesis of periodic protein materials. Journal of Bioactive and Biocompatible Polymers 6:326-338 (1991).

    Google Scholar 

  7. D. W. Urry, C. M. Harris, C. X. Luan, C.-H. Luan, D. C. Gowda, T. M. Parker, S. Q. Peng, and J. Xu. Transductional protein-based polymers as new controlled-release vehicles. In K. Park (ed.), Controlled Drug Delivery: Challenges and Strategies, American Chemical Society, Washington D.C., 1997, pp. 405-437.

    Google Scholar 

  8. M. T. Krejchi, E. D. T. Atkins, A. J. Wadon, M. J. Fournier, T. L. Mason, and D. A. Tirrell. Chemical sequence control of β-sheet assembly in macromolecular crystals of periodic polypeptides. Science 265:1427-1432 (1994).

    Google Scholar 

  9. A. Wada, T. Shimayama, D.-M. Zhou, M. Warashina, M. Orita, T. Koguma, J. Ohkawa, and K. Raira. Ribozymes as antiviral agents. In K. Park (ed.), Controlled Drug Delivery: Challenges and Strategies, American Chemical Society, Washington D.C., 1997, pp. 357-385.

    Google Scholar 

  10. J. Cappello and F. Ferrari. Microbial production of structural protein polymers. In D. P. Mobley (ed.), Plastics from Microbes, Hanser Publishers, New York, 1994, pp. 35-92.

    Google Scholar 

  11. D. W. Urry, K. Okamoto, R. D. Harris, C. F. Hendrix, and M. M. Long. Synthetic, cross-linked polypentapeptide of tropoelastin: an anisotropic, fibrillar elastomer. Biochemistry 15:4083-4094 (1976).

    Google Scholar 

  12. J. Cappello, J. Crissman, M. Dorman, M. Mikolajczak, G. Textor, M. Marquet, and F. Ferrari. Genetic engineering of structural protein polymers. Biotechnol. Prog. 6:198-202 (1990).

    Google Scholar 

  13. J. Cappello. Application of genetically engineered protein polymers to drug delivery. Proceedings of the Eighth International Symposium on Recent Advances in Drug Delivery Systems. Salt Lake City, Utah, February 24–27, pp. 68-71, 1997.

  14. D. W. Urry, D. T. McPherson, J. Xu, G. D. Channe, and T. M. Parker. Elastic and plastic protein-based polymers: potential for industrial uses. In D. P. Mobley (ed.), Plastics from Microbes, Hanser Publishers, New York, 1994, pp. 259-281.

    Google Scholar 

  15. D. W. Urry. Free energy transduction in polypeptides and proteins based on inverse temperature transitions. Prog. Biophys. Molec. Biol. 57:23-57 (1992).

    Google Scholar 

  16. J. Cappello, G. Textor, and B. Bauerle. Bioresorption of implanted protein polymer films controlled by adjustment of their silk/elastin block lengths. In G. G. Gebelien and C. E. Carraher (eds.), Industrial Biotechnological Polymers, Technomic Publishing Company, Lancaster, 1995, pp. 249-256.

    Google Scholar 

  17. A. J. Domb (ed.). Polymeric Site-Specific Pharmacotherapy, John Wiley & Sons, New York, 1994.

    Google Scholar 

  18. D. Putnam and J. Kopecek. Polymer conjugates with anticancer activity. Advances in Polymer Science 122:55-123 (1995).

    Google Scholar 

  19. I. Saiki, J. Iida, J. Murata, R. Ogawa, N. Nishi, K. Sugimura, S. Tokura, and I. Azuma. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. Can. Res. 49:3815-3822 (1989).

    Google Scholar 

  20. E. Yoshikawa, M. J. Fournier, T. L. Mason, and D. A. Tirrell. Genetically engineered fluoropolymers. Synthesis of repetitive polypeptides containing p-fluorophenylalanine residues. Macromolecules 27:5471-5475 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, University, University of Mississippi, Mississippi, 38677

    Hamidreza Ghandehari

  2. Protein Polymer Technologies, Inc., 10655 Sorrento Valley Road, San Diego, California, 92121

    Joseph Cappello

Authors
  1. Hamidreza Ghandehari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Cappello
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghandehari, H., Cappello, J. Genetic Engineering of Protein-Based Polymers: Potential in Controlled Drug Delivery. Pharm Res 15, 813–815 (1998). https://doi.org/10.1023/A:1011999810298

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011999810298

Search

Navigation